FLORINEF 0.1 MG
FLUDROCORTISONE 21-ACETATE : 0.1 MG · DIN 02086026 · ENDO OPERATIONS LTD.
Health Canada status: MARKETED
What is FLORINEF?
FLORINEF 0.1 MG contains FLUDROCORTISONE 21-ACETATE : 0.1 MG. It is listed in the Health Canada Drug Product Database under DIN 02086026, held by ENDO OPERATIONS LTD., supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 24-Mar-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is FLORINEF used for?
FLORINEF (fludrocortisone acetate tablets) is indicated as a partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison’s disease and for the treatment of salt-losing adrenogenital syndrome.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02086026 |
|---|---|
| Brand name | FLORINEF |
| Generic / active ingredient | FLUDROCORTISONE 21-ACETATE : 0.1 MG |
| Manufacturer | ENDO OPERATIONS LTD. |
| Strength | 0.1 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | H02AA02 FLUDROCORTISONE |
| AHFS class | 68:04.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 24-Mar-2026 |
| Original market date | 1995-12-31 00:00:00 |
How is it stored and handled?
null
How is it supplied?
bottles of 100 counts
What can be used instead?
Other Canadian products sharing ATC code H02AA02 FLUDROCORTISONE. 2 of 3 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| JAMP FLUDROCORTISONE | 0.1 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02552248 |
| FLORINEF ACETATE 0.1MG | .1 MG | TABLET | SQUIBB CANADA INC., DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | CANCELLED POST MARKET | DIN 00029351 |
Who else supplies FLUDROCORTISONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. FLUDROCORTISONE appears in 9 registered pack listings across 6 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.